2001
DOI: 10.1006/abio.2001.5026
|View full text |Cite
|
Sign up to set email alerts
|

Biosensor Analysis of Drug–Target Interactions: Direct and Competitive Binding Assays for Investigation of Interactions between Thrombin and Thrombin Inhibitors

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
47
0

Year Published

2001
2001
2017
2017

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 33 publications
(48 citation statements)
references
References 0 publications
1
47
0
Order By: Relevance
“…Zero-concentration blank buffer cycles were included as negative control samples. Solvent-correction procedures were included to compensate for any DMSO-related bulk refractive index variations and performed as described (34). Nonspecific odorant binding to antipolyhistidine-derivatized sensor surfaces was absent for all analyses reported.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…Zero-concentration blank buffer cycles were included as negative control samples. Solvent-correction procedures were included to compensate for any DMSO-related bulk refractive index variations and performed as described (34). Nonspecific odorant binding to antipolyhistidine-derivatized sensor surfaces was absent for all analyses reported.…”
Section: Methodsmentioning
confidence: 99%
“…Data were prepared by subtraction of reference surface data and blank buffer sample data, a procedure commonly referred to as ''double referencing'' (35). Solvent correction was applied as described (34). A plot of the corrected equilibrium odorant binding responses versus odorant concentration was fitted by using the following equation to yield the K D value: Req ϭ KA C Rmax/KA C ϩ 1, where Req is the odorant binding response at equilibrium, C is the odorant concentration, Rmax is the maximum binding capacity of the captured receptor, and KA is the association equilibrium constant.…”
Section: Methodsmentioning
confidence: 99%
“…The major advantages are low target consumption (a few mg protein/microplate compounds), the possibility to simultaneously use reference proteins (to discriminate between selective and promiscuous binders) and that it resolves affinity into on/off-rate constants, improving structure-activity relationship studies. The study of direct binding between low molecular weight compounds and target molecules was developed by Helena Danielson at Uppsala University, Sweden in collaboration with scientists at Biacore, AB (Markgren et al, 1998(Markgren et al, , 2002Alterman et al, 2001;Hämäläinen et al, 2000;Karlsson et al, 2000). The use of optical biosensors in drug discovery has recently been reviewed (Cooper, 2002(Cooper, , 2003aMyszka and Rich, 2000;Rich and Myszka, 2004;Karlsson, 2004;Löfås, 2004).…”
Section: Introductionmentioning
confidence: 96%
“…After a period of silence, several SPR papers appeared on the topic of conformation-dependent sensing despite many considering the reports to be simply anomalous behavior (43)(44)(45)(46)(47), attributed to the following: (i) buffer mismatch, (ii) volume exclusion due to ligand density differences (43)(44)(45), (iii) nonspecific matrix interaction (46), and (iv) nonspecific reference interactions (47). Regardless, a recent paper reported that the RI sensing figures of merit were dependent on shape and the size of the Au nanoparticles (48) with sensitivities generally increasing as the nanoparticles became elongated and their apexes become sharper.…”
Section: Introductionmentioning
confidence: 99%